top of page
lines2_edited_edited.jpg

spsMOSAICS

spsMOSAICS delivers an advanced multi-risk, latent class modelling pipeline (Rowley et al., 2017) capable of capturing the key characteristics of complex, heterogeneous cohorts. Effective subgroup estimation, survival estimates cleaned of informative censoring effects, and Bayesian model selection, together make spsMOSAICS the ideal pipeline to robustly estimate cohort substructure.

Survival analysis is often complicated by latent cohort or disease heterogeneity, arising from variations in risk associations or baseline risk trajectory, and informative censoring when the event times of competing risks are not independent. To avoid incorrect inferences and interpretations when analysing complex cohorts a method that accounts for latent heterogeneity is needed.

spsMOSAICS has been developed to estimate latent cohort heterogeneity whilst also accounting for the impact of informative censoring from competing risks in survival estimates. Applicable to both time-to-event or ordinal class type data, spsMOSAICS estimates relative frailties, baseline hazard rates, covariate associations and hazard ratios, 95% confidence intervals and p-values for each modelled risk and each latent class. Benefitting from both Bayesian regression and Bayesian model selection, the pipeline optimally estimates a cohort’s substructure with little risk of overfitting. With the addition of both retrospective and prospective subgroup assignment, spsMOSAICS is ideally suited to robustly identifying differing disease trajectories and, potentially, those patients most likely to benefit from a given treatment.

 

Other features include:

  • Determination of the number of statistically significant patient subgroups in a clinical data set

  • The sizes and detailed characteristics of each subgroup, including differences in frailties, risk associations, or base hazard rates

  • Probabilities for individual patients to belong to each detected subgroup

  • Whether and how subgroup membership can be predicted from the data

  • Simultaneous analysis of multiple risks, enabling survival estimates to be cleaned of informative censoring

  • Fully automated analysis reports, including survival curves

lines2.jpg

spsMOSAICS in research

  • Latent heterogeneity of muscle‐invasive bladder cancer in patient characteristics and survival: A population‐based nation‐wide study in the Bladder Cancer Data Base Sweden (BladderBaSe). Cancer Medicine, 12(12), 13856–13864. Häggström, C., et al. (2023). https://doi.org/10.1002/cam4.5981

​​

  • HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial. JNCI: Journal Of The National Cancer Institute, 112(9), 944–954. Barber, P. R., et al. (2019). https://doi.org/10.1093/jnci/djz231

​​

  • ​Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus. International Journal Of Cancer, 143(8), 1868–1875. Häggström, C., et al. (2018). https://doi.org/10.1002/ijc.31587

​​

​​

  • Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis. BMC Cancer, 15(1).Wulaningsih, W., et al. (2015). https://doi.org/10.1186/s12885-015-1928-z

Interested in purchasing or trying our licence?

lines2_edited_edited.jpg
bottom of page